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LOCALIZATION OF ADRENOCORTICOTROPIC HORMONE-PRODUCING PULMONARY 
CARCINOID BY SOMATOSTATIN RECEPTOR SCINTIGRAPHY 
Todd M. Dewey, MD, a Henry Yeung, MD, b and Robert J. Downey, MD, a'c New York, N.Y. 
We report the case of a 67-year-old woman with 
Cushing's yndrome in whom somatostatin receptor scin- 
tigraphy was used to localize a corticotropin-producing 
pulmonary carcinoid tumor. Over several years, the pa- 
tient had worsening depression, lower extremity edema, 
glucose intolerance, and severe muscle weakness. Even- 
tually, she was taken comatose to another hospital. Initial 
evaluation revealed a serum potassium concentration of 
1.9 mmol/L and a serum adrenocorticotropic hormone 
level of 132 pmol/L (normal range 9 to 52 pmol/L). 
Computed tomograms and magnetic resonance images of 
the abdomen and brain did not reveal any abnormalities. 
Thoracic computed tomography revealed a solitary 8 mm 
nodule in the peripheral right upper lobe without medi- 
astinal adenopathy (Fig. 1). The patient was transferred to 
the Thoracic Surgical Service of Memorial Sloan-Ketter- 
ing Cancer Center. Serum renin, aldosterone, calcitonin, 
and gastrin levels were within normal limits. Low- and 
high-dose dexamethasone suppression tests were per- 
formed without suppression f either serum or urinary 
cortisol levels. Somatostatin receptor scintigraphy demon- 
strated increased uptake in the right upper lobe of the 
lung that corresponded to the nodule seen on the com- 
puted tomographic scan; no additional abnormal areas of 
uptake were identified (Fig. 2). Through a limited right 
anterior thoracotomy, a 9 mm well-circumscribed nodule 
was excised from the anterior segment of the right upper 
lobe. Histologic examination revealed a well-differentiated 
pulmonary carcinoid tumor with positive staining for corti- 
cotropin hormone. Within several days, glucose and electro- 
lyte levels returned to normal values, her depression lifted, 
and, with rehabilitation, muscle strength improved. 
A corticotropin-secreting bronchial carcinoid may be an 
occult cause of Cushing's yndrome. These well-differen- 
tiated neoplasms originate from the neuroendocrine c lls 
of the bronchial mucosa and may remain clinically silent 
until the stigmata of hypercortisolism appear. Computed 
tomograms and magnetic resonance images of the brain, 
together with bilateral petrosal sinus sampling, will reli- 
ably distinguish pituitary from ectopic corticotropin-pro- 
ducing tumors. In two thirds of patients with Cushing's 
syndrome, the source of corticotropin production is small- 
cell carcinoma of the lung. 1 A high percentage of patients 
with small-cell ung cancer will have asymptomatic eleva- 
tions of serum corticotropin, and clinically apparent Cush- 
ing's syndrome will be present in 2%. 2 Small-cell ung 
cancer is usually radiographically apparent; if not present, 
localizing an ectopic site of corticotropin production 
within the thorax can be difficult, because the next most 
common cause, pulmonary carcinoid tumors, are rare, 
often small, and often not readily distinguishable from 
other types of indeterminate lung nodules. If an indeter- 
minate nodule is seen, establishing a diagnosis i  problem- 
atic: transthoracic needle aspiration is associated with a 
significant false negative rate and exploration of the 
thorax by either thoracotomy or video-assisted techniques 
in the severely myopathic patient carries increased risks. 
Recently, somatostatin receptors have been found to be 
expressed in the majority of carcinoid tumors. In vitro 
autoradiographic labeling of somatostatin analog binding 
sites was demonstrated in 54 of 62 carcinoid tumors 3and 
correlates well with anatomic localization by somatostatin 
receptor scintigraphy. 4 
Activated leukocytes, as accumulate in pulmonary gran- 
ulomas or hilar lymph nodes with some autoimmune 
disorders, can be a source of false positive somatostatin 
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Fig. 1. TIx~racic computed tomogram demonstrates a 
solitary : n indeterminate right upper lobe nodule. 
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Fig. 2. Somatostatin receptor scintigraphy demonstrates 
increased uptake in the right upper lobe (arrow) correspond- 
ing to the nodule seen on computed tomographic s an. 
receptor scans. 5 False positive lung scans have also 
been noted to result from increased hilar uptake after 
an upper respiratory tract infection, external beam 
irradiation, bleomycin administration, or surgical treat- 
ment. 5However, if interpreted in an appropriate clini- 
cal setting, somatostatin receptor scintigraphy may pro- 
vide an accurate, noninvasive technique for the 
characterization f indeterminate pulmonary nodules 
as hormonally active and should be considered in the 
diagnostic evaluation of the patient with Cushing's 
syndrome. 
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PULSATING MASS AT THE STERNUM: A PRIMARY CARCINOMA OF ECTOPIC MEDIASTINAL 
THYROID 
Juhani Sand, MD, a Erkki Pehkonen, MD, a Jorma Mattila, MD, b Seppo Seppfinen, MD, c and Jorma Salmi, MD, a 
Tampere, Finland 
During embryogenesis the descent of the thymus, thyroid, 
and parathyroid glands may be disturbed, leading to various 
possibilities for anomalous locations of each gland. One of 
the aberrant locations of the ectopic thyroid is the medias- 
tinum. Rarely, a mass in the anterior upper mediastinum 
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may be a primary mediastinal goiter. 1 Even more rare is 
primary carcinoma in the ectopic mediastinal thyroid. 2 
Case report. A 62-year-old woman was referred to 
Tampere University Hospital in 1993 because of a palpa- 
ble pulsating tumor in the sternum. The patient was free 
of symptoms and in good general condition. Eight years 
earlier she had been operated on for a benign follicular 
goiter and 6 years earlier she had had abenign gastric ulcer. 
Clinical examination revealed a mass in the middle 
portion of the sternum with a clear pulsation. Palpation of 
the neck demonstrated a pretracheal thyroid of normal 
size without abnormal nodules. Doppler examination 
demonstrated a strong whizzing sound in the tumor 
during systole. The chest x-ray film showed a weak soft 
tissue expansion behind the sternum (Fig. 1). A strongly 
vascularized tumor or arteriovenous fi tula was suspected 
and angiography was performed. The angiogram revealed 
a vascular tumor behind the sternum with vascular supply 
from both internal thoracic arteries (Fig. 2). The vascular 
